These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 22449332)

  • 1. Effect of Periodic Granulocyte Colony-Stimulating Factor Administration on Endothelial Progenitor Cells and Different Monocyte Subsets in Pediatric Patients with Muscular Dystrophies.
    Eljaszewicz A; Sienkiewicz D; Grubczak K; Okurowska-Zawada B; Paszko-Patej G; Miklasz P; Singh P; Radzikowska U; Kulak W; Moniuszko M
    Stem Cells Int; 2016; 2016():2650849. PubMed ID: 26770204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are There Any Cardioprotective Effects or Safety Concerns of Erythropoietin in Patients With Myocardial Infarction? A Systematic Review.
    Jean-Baptiste W; Yusuf Ali A; Inyang B; Koshy FS; George K; Poudel P; Chalasani R; Goonathilake MR; Waqar S; George S; Mohammed L
    Cureus; 2022 Jun; 14(6):e25671. PubMed ID: 35812547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Harms of off-label erythropoiesis-stimulating agents for critically ill people.
    Mesgarpour B; Heidinger BH; Roth D; Schmitz S; Walsh CD; Herkner H
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD010969. PubMed ID: 28841235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hematopoietic system in the context of regenerative medicine.
    Porada CD; Atala AJ; Almeida-Porada G
    Methods; 2016 Apr; 99():44-61. PubMed ID: 26319943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of off-label erythropoiesis stimulating agents in critically ill patients: a meta-analysis.
    Mesgarpour B; Heidinger BH; Schwameis M; Kienbacher C; Walsh C; Schmitz S; Herkner H
    Intensive Care Med; 2013 Nov; 39(11):1896-908. PubMed ID: 23928897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. G-CSF enhances resolution of Staphylococcus aureus wound infection in an age-dependent manner.
    Brubaker AL; Kovacs EJ
    Shock; 2013 Oct; 40(4):327-33. PubMed ID: 23856924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granulocyte-colony stimulating factor therapy to induce neovascularization in ischemic heart disease.
    Ripa RS
    Dan Med J; 2012 Mar; 59(3):B4411. PubMed ID: 22381094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Efficacy and Safety of Granulocyte Colony-Stimulating Factor for Patients with Stroke.
    Fan ZZ; Cai HB; Ge ZM; Wang LQ; Zhang XD; Li L; Zhai XB
    J Stroke Cerebrovasc Dis; 2015 Aug; 24(8):1701-8. PubMed ID: 26004861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter, prospective, randomized, controlled trial evaluating the safety and efficacy of intracoronary cell infusion mobilized with granulocyte colony-stimulating factor and darbepoetin after acute myocardial infarction: study design and rationale of the 'MAGIC cell-5-combination cytokine trial'.
    Kang HJ; Kim MK; Kim MG; Choi DJ; Yoon JH; Park YB; Kim HS
    Trials; 2011 Feb; 12():33. PubMed ID: 21299845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: the MAGIC Cell-3-DES randomized, controlled trial.
    Kang HJ; Lee HY; Na SH; Chang SA; Park KW; Kim HK; Kim SY; Chang HJ; Lee W; Kang WJ; Koo BK; Kim YJ; Lee DS; Sohn DW; Han KS; Oh BH; Park YB; Kim HS
    Circulation; 2006 Jul; 114(1 Suppl):I145-51. PubMed ID: 16820564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral blood stem cell mobilisation by granulocyte-colony stimulating factor in patients with acute and old myocardial infarction for intracoronary cell infusion.
    Chang SA; Kang HJ; Lee HY; Kim KH; Hur J; Han KS; Park YB; Kim HS
    Heart; 2009 Aug; 95(16):1326-30. PubMed ID: 19460773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of left ventricular remodeling with granulocyte colony-stimulating factor after acute myocardial infarction: final 1-year results of the Front-Integrated Revascularization and Stem Cell Liberation in Evolving Acute Myocardial Infarction by Granulocyte Colony-Stimulating Factor (FIRSTLINE-AMI) Trial.
    Ince H; Petzsch M; Kleine HD; Eckard H; Rehders T; Burska D; Kische S; Freund M; Nienaber CA
    Circulation; 2005 Aug; 112(9 Suppl):I73-80. PubMed ID: 16159869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and feasibility of combined granulocyte colony stimulating factor and erythropoetin based-stem cell therapy using intracoronary infusion of peripheral blood stem cells in patients with recent anterior myocardial infarction: one-year follow-up of a phase 1 study.
    Santoso T; Irawan C; Alwi I; Aziz A; Kosasih A; Inggriani S; Saputra A; Wintery M; Lison L
    Acta Med Indones; 2011 Apr; 43(2):112-21. PubMed ID: 21785174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cotreatment with darbepoetin and granulocyte colony-stimulating factor is efficient to recruit proangiogenic cell populations in patients with acute myocardial infarction.
    Kang HJ; Yoon EJ; Lee EJ; Kim MK; Suh JW; Park KW; Lee HY; Park KU; Cho YS; Koo BK; Chae IH; Choi DJ; Han KS; Kim HS; Park YB
    Cell Transplant; 2012; 21(5):1055-61. PubMed ID: 22449332
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.